A detailed history of Paladin Wealth, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Paladin Wealth, LLC holds 8,740 shares of DXCM stock, worth $507,444. This represents 0.43% of its overall portfolio holdings.

Number of Shares
8,740
Previous 8,604 1.58%
Holding current value
$507,444
Previous $751 Million 21.69%
% of portfolio
0.43%
Previous 0.58%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 14, 2025

BUY
$66.46 - $89.53 $9,038 - $12,176
136 Added 1.58%
8,740 $588 Million
Q2 2025

Jul 08, 2025

SELL
$59.83 - $87.57 $23,812 - $34,852
-398 Reduced 4.42%
8,604 $751 Million
Q1 2025

Apr 09, 2025

BUY
$67.74 - $90.75 $33,057 - $44,286
488 Added 5.73%
9,002 $615 Million
Q4 2024

Jan 29, 2025

BUY
$65.68 - $81.01 $143,116 - $176,520
2,179 Added 34.4%
8,514 $662 Million
Q3 2024

Oct 11, 2024

BUY
$64.0 - $116.06 $405,440 - $735,240
6,335 New
6,335 $425 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $22.4B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Paladin Wealth, LLC Portfolio

Follow Paladin Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paladin Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paladin Wealth, LLC with notifications on news.